EFFICACY AND SAFETY OF MICROPROCESSOR-CONTROLLED PROSTHESES IN TRANSFEMORAL AMPUTEES: A SYSTEMATIC REVIEW OF CONTROLLED STUDIES

Abstract

This article aimed to evaluate the efficacy and safety of microprocessor-controlled prostheses in patients with unilateral transfemoral amputation (UTA). Methods: A systematic review was conducted following the PRISMA guidelines, searching the Medline/PubMed, Cochrane, and Embase databases. Sixteen studies were included, of which 11 were randomized clinical trials. Results: Microprocessor-controlled prostheses demonstrated superiority in several mobility tests, with statistical significance (p < 0.05) in tests such as TUG and 10MWT, in addition to reducing falls, improving quality of life, and promoting greater satisfaction with the prosthesis, also with statistical significance, particularly in MFCL K2 and K3 patients. Furthermore, it was shown that individuals with lower mobility may benefit more from C-Leg® and Kenevo®, while those in a younger age range and with greater mobility may benefit more from Genium®. Conclusion: MPKs provide functional and safety benefits in patients with transfemoral amputation, especially at the K2 and K3 levels. Genium® appears more suitable for younger and more active patients, while C-Leg® offers a good balance between functionality and safety.